C ontroversy exists over appropriate fluid management for acute renal failure patients (1) (2) (3) (4) (5) (6) (7) (8) . In the acute care setting, loop diuretics are often prescribed to maintain or increase urine output.
Furosemide and other loop diuretics reduce oxygen demand in the medullary thick ascending limb and attenuate the severity of acute renal failure (ARF) in animal models (4, 5) . They may protect the human kidney from ischemic injury. There have been several small, randomized, controlled trials of diuretics for the treatment or prevention of ARF in various clinical settings (8 -20) . Some studies showed a reduction in dialysis requirement (15) , reduced urinary albumin and N-acetyl glucosaminidase concentration (17) , or improved dialysis free survival in oliguric patients (18) . Others, however, showed either worsened renal function (10, 12, 14, 16) or no difference in various measured outcomes (8, 9, 11, 13, 19, 20) .
Recently, Mehta et al. (21) published an observational study of diuretic use in patients with ARF in the setting of critical illness and showed that, using multivariate analysis and propensity scores, the use of diuretics was associated with an increased risk of death. The methodology used by Mehta et al. (21) was similar to a propensity score adjusted assessment of pulmonary artery catheter use in the critically ill (22) . The use of propensity score models, however, has significant potential shortcomings (23, 24) , which, together with the limited sample size and the use of only three centers, may have resulted in misleading conclusions.
The statistics used in this study might have also led to incorrect conclusions because of the phenomenon of collinearity: using physiological variables that are often highly correlated (collinear) with each other (e.g., blood urea nitrogen and serum creatinine) can lead to nonsensical results in multivariate analyses (24) . When collinearity is detected, there are two main approaches that can be used to ensure that results are reliable: a) Reduce the number of variables considered before undertaking multiple regression; or b) use appropriate statistical techniques to investigate and address potential correlations between variables. This was not done in Mehta et al.'s (21) study.
Given the importance of understanding the complex relationship between diuretics and mortality in critically ill patients, we used a comprehensive analytic approach to test the hypothesis that diuretic use affects mortality. Using a large, multinational, multiple-center, prospective database, we investigated the association between diuretic use and outcome using a) a propensity score adjusted multivariate model containing terms previously identified to be important predictors of outcome; b) a new propensity score adjusted multivariate model; and c) a multivariate model developed using standard methods, compensating for collinearity.
MATERIALS AND METHODS
Fifty-four study sites in 23 countries were contacted and invited to participate. A deliberate attempt was made to have a wide variety of countries, continents, and hospital types (academic centers, private hospitals, nonacademic urban hospitals, etc.) participate in the study (see the appendix for complete details). Because of the anonymous and noninterventional fashion of this study, ethical committees in most centers waived the need for informed consent. Where ethics committees or investigational review boards required informed consent, this was obtained.
Study Population. All patients who were admitted to any of the participating intensive care units (ICUs) during the observational period were considered. From this population, only patients who had at least one of the predefined criteria for ARF were included in the study. The criteria for ARF were as follows:
1. Requirement for renal replacement therapy (RRT), and/or 2. Oliguria defined as urine output Ͻ200 mL in 12 hrs 3. Anuria defined as urine output Ͻ50 mL in 12 hrs 4. Marked acute azotemia defined as a plasma urea Ͼ30 mmol/L or blood urea nitrogen Ͼ86 mg/dL 5. Hyperkalemia defined as serum potassium Ͼ6.5 mmol/L These criteria were chosen because they are simple, objective, numerically identifiable, and clinically relevant. Patients with any dialysis treatment before admission to the ICU or patients with end-stage renal failure on chronic dialysis were excluded.
Data Collection. A case report form was developed for the purpose of the study, and relevant demographic, clinical, illness severity related (25) , renal function specific (26) , biochemical, and therapeutic intervention data were recorded.
Rationale and Methodology of Statistical Analysis. The evaluation of data from observational studies often reveals that physiological variables are highly correlated with each other (e.g., serum sodium with serum chloride levels). When the degree of correlation between variables entered in multiple regression equation exceeds a certain level, regression models can lead to unstable variable estimates, incorrect variance estimates, and difficulties in the numerical calculations involved in fitting the model (24) . One of the most widely accepted ways of detecting multicollinearity is to calculate the eigenvalues associated with the predictor variable correlation matrix to determine the condition number (27) (28) (29) (30) . The condition number is the ratio of the largest eigenvalue to the smallest eigenvalue (30) .
When multicollinearity is detected, simple linear transformations of the data that do not result in information loss can often be used to improve model performance (27) .
Given the need to address the problems associated with multicollinearity, three distinct multivariate models were used to explore the relationship between diuretic use and mortality: method 1, a propensity score adjusted multivariate model containing the same terms found to be important in Mehta et al.'s study (21) ; method 2, a propensity score adjusted multivariate model containing terms identified using the same analytic technique as used by Mehta et al. (21) ; and method 3, a multivariate model considering all available covariates, which involved a formal assessment of multicollinearity using eigenanalysis and linear transformations.
Method 1: Confirmatory Propensity Adjusted Mortality Model. Method 1 involved two distinct logistic regression models.
Step 1 required the development of a logistic regression model, predicting diuretic use, to calculate a propensity score for treatment with diuretics. This score represents the probability of treatment with diuretics and was then included in a subsequent logistic regression model predicting mortality. The propensity score logistic regression model developed in step 1 contained the following variables previously identified to be important predictors of diuretic use: patient age, nephrotoxic etiology of ARF, blood urea nitrogen, and presence of acute respiratory failure (21) .
In step 2, a model predicting mortality was developed. This second logistic regression model contained the following terms previously identified to be important predictors of mortality: diuretic use, propensity score, patient age, gender and first consultation day values for heart rate, blood urea nitrogen, creatinine, urine output, and respiratory, hematologic, and liver failure (21, 25) Method 2: New Propensity Adjusted Mortality Model. Method 2 involved the development of a propensity adjusted mortality model using the same methodology, inclusion criteria, and p value thresholds as Mehta et al. (21) , which required a two-step process as described in method 1. However, all possible predictors of outcome were screened for inclusion in the maximum models using univariate logistic regression. In step 1, the maximum model contained all univariate predictors of diuretic use with p Ͻ .25. A backward stepwise elimination process was then used to remove covariates whose multivariate p value was Ͼ.25. The final new propensity score model contained all predictors of diuretic use with a multivariate p Ͻ .25 (21) .
In step 2, the new propensity adjusted mortality model contained all eligible univariate predictors of mortality along with terms for diuretic use and the new propensity score developed in step 1. Logistic regression was used to identify predictors of mortality, and a univariate p Ͻ .25 qualified the variable for consideration in the maximum model. The terms diuretic use and new propensity score were forced to remain in the model, and a backward stepwise elimination process was used to remove any other covariates whose multivariate p value was Ͼ.10 (26). The final model contained the terms diuretic use, new propensity score, and all other predictors of mortality with a multivariate p Ͻ .10.
Method 3: Multicollinearity Adjusted Model. Logistic regression was used to identify all potential confounding variables associated with either diuretic use or mortality. A univariate p Ͻ .25 qualified the variable for inclusion in the maximum model (28) .
The maximum model was formally assessed for the presence of multicollinearity using eigenanalysis, with a condition number Ն30 considered to be indicative of moderate to severe collinearity (29) . The presence of moderate to severe collinearity was addressed by standardizing (transforming to the z-scale) all continuous independent variables (31), the success of which was again assessed using eigenanalysis.
After we investigated the presence of, and adjusted for, multicollinearity, the maximum model was entered into a stepwise backward elimination model selection process. All covariates with a multivariate p Ͼ .10 were removed from the model (31, 28, 29) .
Method Comparisons. After generation of the final predictive models, overall performance was assessed using measures of calibration and discrimination. Calibration was assessed with the Hosmer-Lemeshow goodnessof-fit statistic (30) , and discrimination was reported using the c-statistic (28), which is numerically equivalent to the area under the receiver operating characteristic curve (32, 33) Each final model was assessed for the presence of multicollinearity, using eigenanalysis with a condition number Ն30 considered to be indicative of moderate to severe collinearity (29, 33) . Final models were also assessed for potential bias arising from the conjoint distribution of missing values.
For propensity score models, the outcome event of diuretic use was modeled as a binary variable, with diuretic use equal to one. For mortality models, the outcome of mortality was modeled as a binary variable with death in hospital equal to one. A marker variable, named count, was set equal to one for all cases. All analysis was conducted in PC SAS (version 6.12, SAS Institute, Cary, NC). Logistic regression analysis was carried out using the events/count model specification in PROC Logist. Eigenanalysis was conducted with Proc Reg, with the collin option specified. We assessed p values for multivariate models using likelihood ratio tests.
RESULTS
We screened 29,269 patients, and 1,758 patients met the eligibility criteria for this study. Among these, 15 patients (0.9%) were excluded because no information about diuretic use was available and 12 patients because of missing hospital outcome information. Diuretics were given to 1,117 (60.8%) patients, with furosemide as the most common choice (1,098 patients, 98.3%). Other diuretics used were various types of loop diuretics in 29 patients, mannitol in 22, metolazone in 19, spironolactone in 18, thiazides in 14, atrial natriuretic peptide in 10, and others in 4. Furosemide and other diuretics were given in combination to 92 patients.
Demographics and admission diagnoses of patients with ARF are shown in Tables 1 and 2. Table 3 contains physiological and laboratory variables at study inclusion, and Table 4 presents patient outcomes. Of note, unadjusted hospital mortality rates were higher for patients receiving diuretics compared with those who did not (62.4% vs. 57.1%; odds ratio [OR], 1.25; p ϭ .03; Table 4 ). However, the difference in hospital mortality rate between groups was no longer significant after we controlled for other variables using all three statistical methods.
Method 1: Confirmatory Propensity Adjusted Mortality Model. After we controlled for propensity score and other variables previously found to be significant predictors of mortality, diuretic use was not found to be significantly related to increased mortality (OR 1.21, p ϭ 0.10). Table 5 presents the regression variables, ORs, and p values for all model covariates. Table 6 presents an in-depth comparison of all cases that could not be included in this model due to missing values. Of all cases with available diuretic use and hospital outcome information, due to missing values in at least one variable required for the logistic regression model, 64 cases could not be included in the final mortality model. The mortality rate in these 64 cases was 48.4% (31 of 64), which was significantly different than the 60.9% (1,016 of 1,667) mortality rate experienced by the cases that could be included in the model (p ϭ .045).
Method 2: New Propensity Adjusted Mortality Model. Variables that demonstrated a univariate p value associated with diuretic use Ͻ.25 and thus qualified for entry into the new propensity score maximum model are listed in Tables 1  and 3 . However, the final propensity score model contained the following variables: patient age, Simplified Acute Physiology Score II score, creatinine at ICU admission, requirement of renal replacement therapy, time from ICU admission to study inclusion, and the following variables measured at study inclusion; central venous pressure, Glasgow Coma Scale score, vasopressor use, urine volume for the 6 hrs preceding inclusion, platelet count, creatinine, arterial pH, septic etiology, low cardiac output etiology, and other etiology.
Variables that demonstrated a univariate p value associated with mortality Ͻ.25 and thus qualified for entry into the final model are listed in Tables 1 and 3. After we controlled for propensity score and other variables found to be significant predictors of mortality, diuretic use was not found to be significantly related to increased mortality rate (OR 1.21, p ϭ .18). Regression variables, ORs, and p values for the final model are presented in Table 7 . ified for entry into the maximum model are listed in Tables 1 and 3 . Before commencing the backward elimination model selection process, we assessed the maximum model for the presence of multicollinearity. Eigenanalysis revealed a condition number of 460.5, demonstrating the presence of severe multicollinearity. To address the presence of severe multicollinearity, all continuous variables were standardized (z-transformed). The condition number for the standardized maximum model was 13.62, indicating that standardization adequately addressed the problem of multicollinearity. The stepwise backward elimination selection process was undertaken on the standardized maximum model. After we controlled for all possible confounding variables, diuretic use was not found to be significantly related to increased mortality (OR 1.22, p ϭ .15). Regression variables, ORs, and p values for the final model are presented in Table  9 . Table 10 presents an in-depth comparison of all cases that could not be included in this model due to missing values. Of all cases with available diuretic use and hospital outcome information, due to missing values in at least one variable required for the final logistic regression model, 327 cases could not be included in the model-building process. The mortality rate in these 327 cases was 60.9% (199 of 327), which was not significantly different than the 60.4% (848 of 1,404) mortality rate experienced by the cases that could be included in the model (p ϭ .879).
Final Model Comparison: Goodness of Fit and Multicollinearity. As measured by the Hosmer-Lemeshow goodness-of-fit statistic and area under the receiver operating characteristic curve, all final models demonstrated good fit and good discrimination (Table 11) .
Eigenanalysis conducted on the final model developed in method 1 revealed a condition number of 54.24, which indicates the presence of severe multicollinearity and may make any measures of association (i.e., regression variables and odds ratios) unreliable. Eigenanalysis conducted on the final model developed in method 2 revealed a condition number of 329.96, which indicates the presence of severe multicollinearity, again making measures of association unreliable. Eigenanalysis of the final model developed in method 3 revealed a condition number of 8.6, suggesting that there was no multicollinearity present in this model.
DISCUSSION
Using a comprehensive statistical approach and a large international prospective database of patients with acute renal failure, we tested the hypothesis that an association existed between the use of diuretics and mortality. We found that, after appropriate statistical adjustment and using three separate methodologies, there was no statistically significant association between the use of diuretics and mortality. Our findings differ from those of a recently published and editorialized investigation (21) . As the issue of diuretic use is important to clinical practice and as complex statistical analyses were used, a discussion of the methodology is necessary.
The purpose of using three different methods for assessing the impact of diuretic use on mortality was not motivated by the desire to determine which method was most appropriate. On the contrary, since allocation to a treatment in an observational study is beyond the control of the investigators, the methodological literature recommends that a propensity score analysis should be conducted in addition to a more traditional analysis (34) . Indeed, in this specific exercise, all three methods resulted in similar findings. Methods 1, 2, and 3 all failed to demonstrate a significant (p m1 ϭ .10, p m2 ϭ .18, p m3 ϭ .15, respectively) relationship between treatment with diuretics and subsequent mortality. It is also interesting to note that the magnitude and direction of the odds ratio between diuretic use and outcome was similar between all three methods (OR m1 1.21, OR m2 1.21, and OR m3 1.22, respectively).
Thus, after we controlled for known differences between groups, an apparent association between diuretics and mortality could not be confirmed. Indeed, the ORs from our models were not very different from the crude mortality data (OR 1.25). Therefore, although our data do not permit us to draw the same conclusion as Mehta et al. (21) , that the "use of diuretics in critically ill patients with acute renal failure should be discouraged," our data do suggest that a clinical trial to evaluate the use of diuretics in acute renal failure is warranted. Using our findings and assuming a baseline mortality rate of 60%, a sufficiently powered randomized controlled trial would need to enroll 4,734 patients to detect a difference in outcome associated with an OR of 1.21 (4% absolute reduction).
Our study differs from the Mehta et al. (21) study in several important ways. First, in our study, approximately 70% of patients were recruited at the time of RRT commencement and we used a higher blood urea nitrogen concentration for the definition ARF (86 mg/dL compared with 40 mg/dL in the previous study). This difference in criteria could have caused a delay in the inclusion of study patients. However, the serum creatinine concentration was lower (e.g., 3.3 vs. 3.6 mg/dL in patients with diuretics), and our patients were included in the study at a median of only 1 day after ICU admission. Therefore, the timing of inclusion is unlikely to have affected our findings.
The choice of diuretics was also different. Most of our patients received furosemide (98%), and other diuretics were rarely used. Thus, we had a more uniform sample in terms of intervention. On the other hand, only 62% of patients in Mehta et al.'s (21) study received furosemide, and other diuretics were also commonly used (bumetanide 58%, metolazone 33%, hydrodiuril 4%). It is possible that the results observed in the Mehta et al. study are attributable to differences in practice patterns not observed in our study. Compared with the previous study, our study was larger, was conducted prospectively, and was multinational in design (54 centers in 23 countries vs. four centers in one country), and the findings are thus more likely to be widely applicable and generalizable. It was also conducted more recently (2000 -2001 vs. 1989 -1995) and with fewer patient exclusions. It should be pointed out that we treated urine output differently. In Mehta et al.'s model, the logarithm of urine output was included as a covariate, whereas we elected not to calculate the log of urine output. Since the logarithm of a zero value is undefined, because many of the patients in our database had no (zero) urine output recorded over the time interval leading to consultation, it is likely that a log transformation of urine output would lead to unnecessary missing values. Mehta et al. (21) did not report what was done with patients who had a zero urine output and thus an undefined (missing) log-urine output.
With regard to other missing values, we have explicitly reported the number of patients with missing values that could not be included in each method, along with the patient outcomes and characteristics (Tables 6, 8 , and 10). These patients tended to be less severely ill and have a better outcome than those that could be included.
The fact that ICU patients who generate missing values in observational studies are more likely to be less severely ill and have better outcomes is well established (35) . Although the potential direction of bias due to missing values was not explicitly addressed, Mehta et al. (21) reported missing values in 35% of all cases. Our overall missing value rate ranged from 5% in method 1 to approximately 20% in method 2 and method 3. Although it is possible that the difference in results between our study and Mehta et al.'s is due to fewer missing values in the current study, it is likely that missing values were generated for similar reasons in both studies. The remarkable similarity of the estimate of the odds ratio (OR m1 1.21, OR m2 1.21, and OR m3 1.22) obtained from all three methods would suggest that missing cases, which differed between all three approaches, likely had little impact.
Although the use of a propensity score can address problems that arise due to multicollinearity, it is interesting to note that the final models obtained by method 1 and method 2 both demonstrated the presence of moderate to severe multicollinearity (condition number Ͼ30). Because we found that propensity scores may not always adequately address problems associated with multicollinearity, we strongly support the recommendation that a propensity score method should not replace more traditional approaches but rather that they "should be thought of as an additional tool available" to investigators and compared directly with the results obtained with more traditional methods (34) . Furthermore, we recommend that formal methods for detecting problems associated with multicollinearity should be employed.
Finally, it is interesting to note that method 3 included a variable representing the presence of a pulmonary artery catheter at study inclusion and, to our surprise, this variable was independently associated with a reduction in mortality rate (OR 0.59, p Ͻ .001). Given these findings, we suggest that perhaps the role of diuretics must be taken into a larger context of fluid and hemodynamic management. We note that in the recently published trial of routine pulmonary artery catheter use (36), acute renal failure was a rare event, but a trend toward a decrease in incidence was seen in the patients receiving a pulmonary artery catheter.
CONCLUSIONS
When causal inferences are addressed, even the use of a propensity score cannot overcome the primary limitation of an observational study: Analytic methods can only adjust for observed confounding variables and not for unobserved ones (23) . Similar to the decision to use a pulmonary artery catheter, the decision to use a diuretic in a critically ill patient could be driven by many factors that may not be adequately captured in an observational database. It is possible that these unquantifiable factors, in and of themselves, are more important in determining an individual patient's outcome than the use of diuretics.
In a large, prospective, multinational cohort, despite rigorous statistical analysis, we could not confirm the findings of Mehta et al. (21) that diuretics are associated with a higher mortality rate in critically ill patients with ARF. Thus, we would not discourage the use of diuretics in such patients. However, we would encourage a clinical trial, which our findings and those of Mehta et al. suggest is both desirable and logistically possible. 
